Enzyme, powered by the MLN token, is a digital asset management platform that strives to streamline the management of digital assets. It provides a unified, user-friendly on-chain system that allows access to digital assets and DeFi from a single application. Enzyme aims to eliminate operational risks associated with managing crypto and DeFi assets without purpose-built smart-contract permissions and controls. It provides a robust suite of programmable risk management and governance tools to protect assets. Enzyme also maintains sophisticated on-chain data pipelines, ensuring data is auditable and trustworthy, promoting a future based on transparency and auditability.

Enzyme operates through a system of vaults, each representing a unique portfolio with its own strategy, asset allocation, and investment goals. Users can create multiple vaults and customize each one according to their preferences. Enzyme provides tools for managing and monitoring these portfolios, including performance metrics and detailed reporting. This makes it easy for users to track the performance of their assets and make informed decisions about how to manage their portfolios over time. Enzyme also provides real-time reporting and performance dashboards with key performance and risk metrics, and reports that provide easily readable and provable data on all transactions at any point in history.

Enzyme has a wide range of potential use cases. For instance, it can be used for treasury management, allowing organizations to manage their treasury simply, securely, and transparently. It can also be used to set up an on-chain DeFi fund, with Enzyme taking care of all fund operations and administration using smart-contract automation. Additionally, users can build their own indexes in minutes and have them rebalance automatically on-chain or off-chain. Enzyme also allows anyone to build, scale, and monetize investment strategies using the protocol's non-custodial Vaults. These strategies can span the spectrum from traditional discretionary allocators to DeFi-native combinations of any of the primitives with which Enzyme integrates.

Enzyme, formerly known as the Melon Protocol, was initially developed by the private company Melonport. After the dissolution of Melonport, the protocol was transferred to the Enzyme Council. The protocol has been on the mainnet since February 2019 and was the first DeFi protocol to decentralize its governance. Enzyme v2, a completely re-architected protocol with modularity and extensibility at the core of its design, was launched to the mainnet in January 2021. The Enzyme token, MLN, is used to access the MLN network and incentivize developers to build on Enzyme.

Aktualizujemy nasz kurs Enzyme do USD w czasie rzeczywistym. Otrzymuj aktualną cenę Enzyme na Coinbase.

Obecna kapitalizacja rynku Enzyme to 4,343 mln USD. Wysoka kapitalizacja rynku oznacza, że aktywa są wysoko cenione przez rynek.

Najwyższy w historii poziom Enzyme to 270,05 USD. Ten rekordowy poziom to najwyższa cena zapłacona za Enzyme od czasu jego wprowadzenia na rynek.

W ciągu ostatnich 24 godzin wolumen obrotu Enzyme wyniósł 1,089 mln USD.

Aktywa o podobnej kapitalizacji rynkowej do Enzyme to m.in. Graphite Protocol, Aspecta, Aragon i wiele innych. Aby zobaczyć pełną listę, zobacz nasze aktywa o porównywalnej kapitalizacji rynkowej.

Obecna podaż w obiegu Enzyme wynosi 3,3 miliona.

Enzyme zajmuje 231 pozycję wśród aktywów zbywalnych na Coinbase. Popularność jest obecnie oparta na względnej kapitalizacji rynku.

Obecnie 63% użytkowników Coinbase kupuje Enzyme. Innymi słowy 63% klientów Coinbase zwiększyło swoją pozycję netto w Enzyme poprzez handel w ciągu ostatnich 24 godzin.